Extranodal cutaneous lymphoma presenting as therapy resistant thrombophlebitis;Intravaskuläres lymphom unter dem klinischen bild einer therapieresistenten thrombophlebitis

Phlebologie

Volumn 34, Issue 3, 2005, Pages 171-175

  Griefingholt, Harold ^a,e   Meyer Zu Vilsendorf, E ^b   Bosse, U ^c   Mentzel, T ^d  

^a Institut für Pathologie Bonn Duisdorf   (Germany)

^b Chirurgisch Phlebologische Praxisgemeinschaft   (Germany)

^c Institut fur Pathologie   (Germany)

^d Dermatopathologische Gemeinschaftspraxis   (Germany)

^e Institut für Pathologie Bonn Duisdorf   (Germany)

Author keywords

Intravascular large T cell lymphoma; Malignant angioendotheliomatosis; Therapy resistant thrombophlebitis

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ANGIOENDOTHELIOMATOSIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DOPPLER ECHOGRAPHY; ERYSIPELAS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; PROGNOSIS; T CELL LYMPHOMA; THROMBOPHLEBITIS; TUMOR DIAGNOSIS;

EID: 21244491178     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621477     Document Type: Article

References (32)

1. Anghel G, Petrinato G, Severino A et al. Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement. Leuk Lymphoma 2003; 44: 1353-9.
2. Ansell J, Bhawan J, Cohen S et al. Histiocytic lymphoma and malignant angioendotheliomatosis: one disease or two? Cancer 1982; 50: 1506-12.
3. Au WY, Shek WH, Nicholls J et al. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein-Barr viral infection. Histopathology 1997; 31: 563-7.
4. Baehring JM, Longtine J, Hochberg FH. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 2003; 61: 237-48.
5. Bhawan J, Wolff SM, Ucci AA et al. Malignant lymphoma and malignant angioendotheliomatosis: one disease. Cancer 1985; 55: 570-6.
6. Carroll TJ Jr, Schelper RL, Goeken JA et al. Neoplastic angioendotheliomatosis: immunpathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol 1986; 85: 169-75.
7. DiGiuseppe JA, Nelson WG, Seifter EJ et al. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994; 12: 2573-9.
8. Domizio P, Hall PA, Cotter F et al. Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 1989; 7: 195-206.
9. Elder DE (ed). Lever's Histopathology of the Skin. Philadelphia PA: Lippincott 2004
10. Ferreri AJ, Campo E, Ambrosetti A et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004; 15: 1215-21.
11. Ferreri AJ, Campo E, Seymour JF et al. International Extranodal Lymphoma Study Group (IELSG): Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004; 127: 173-83.
12. Ferry JA, Harris NL, Picker LJ et al. Intravascular lymphomatosis (malignant angioendotheliomatosis): a B-cell neoplasm expressing surface homing receptors. Mod Pathol 1988; 1: 444-52.
13. Flaig MJ, Sander CA. Diagnostik kutaner B-Zell-Lymphome. Pathologe 2000; 21: 190-6.
14. Frisch P. Dermatologie und Venerologie. Berlin, Heidelberg: Springer 1998.
15. Fulling KH, Gersell DJ. Neoplastic angioendotheloimatosis. Histologic, immunhistochemical and ultrastructural findings in two cases. Cancer 1983; 51: 1107-18.
16. Hsiao CH, Su IJ, Hsieh SW et al. Epstein-Barr-virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient. Am J Surg Pathol 1999; 23: 482-7.
17. Jaffe ES, Harris NL, Stein H (eds). World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tissues. Lyon: IARC Press 2001.
18. Jalkanen S, Aho R, Kallajoki M et al. Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. Int J Cancer 1989; 44: 777-82.
19. Kerl H, Garbe C, Cerroni L et al. (eds). Histopathologie der Haut. Heidelberg: Springer 2003.
20. Khalidi HS, Brynes RK, Browne P et al. Intravascular large B-cell-lymphoma: the CD 5 antigen is expressed by a subset of cases. Mod Pathol 1998; 11: 983-8.
21. Kitagawa M, Matsubara O, Song SY et al. Neoplastic angioendotheloimatosis. Immunhistochemical and electron microscopic findings in three cases. Cancer 1985; 56: 1134-43.
22. Pfleger L, Tappeiner J. Zur Kenntnis der systematischen Endotheliomatose der kutanen Blutgefäße (Reticuloendotheliose). Hautarzt 1959; 10: 359-63.
23. Ponzoni M, Arrigoni G, Gould VE et al. Lack of CD 29 (beta 1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000; 31: 220-6.
24. Sepp N, Schuler G, Romani N et al. Intravascular lymphomatosis (angioendotheloimatosis): Evidence for a T-cell origin in two cases. Hum Pathol 1990; 21: 1051-8.
25. Sheibani K, Battifora H, Winberg CD et al. Further evidence that malignant angioendotheloimatosis is an angiotropic large-cell lymphoma. N Engl J Med 1986; 314: 943-8.
26. Snowden JA, Angel CA, Winfield DA et al. Angiotropic lymphoma: Report of a case with histiocytic features. J Clin Pathol 1997; 50: 67-70.
27. Takacs I, Eros N, Bene I et al. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy. Ann Hematol 2004; 83: 608-10.
28. Tappeiner J, Pfleger L. Angioendotheliomatosis proliferans systematisata: Ein klinisch und pathologisch neues Krankeitsbild. Hautarzt 1963; 14: 67-70.
29. Weichert G, Martinka M, Rivers JK. Intravascular lymphoma presenting as telangectasias: Response to rituximab and combination chemotherapy. J Cutan Med Surg 2003; 7: 460-3.
30. Wick MR, Banks PM, McDonald TJ. Angioendotheliomatosis of the nose with fatal systemic dissemination. Cancer 1981; 48: 2510-7.
31. Wick MR, Mills SE, Scheithauer BW et al. Reassessment of malignant angioendotheliomatosis. Evidence in favor of its reclassification as "intravascular lymphomatosis". Am J Surg Pathol 1986 10: 112-23.
32. Wrotnowski U, Mills SE, Cooper PH. Malignant angioendotheliomatosis: An angiotropic lymphoma? Am J Clin Pathol 1985; 83: 244-8.